Error: Could not add to watchlist. X

Transition Therapeutics Inc

+ Watchlist
TTHI:US
NASDAQ GM
2.17
USD
0.06
2.84%
As of 20:10:00 ET on 07/03/2015.
Open
2.07
Day Range
2.03 - 2.17
Volume
180,071
Previous Close
2.11
52Wk Range
2.02 - 9.30
1 Yr Return
-68.55%
Current P/E Ratio (TTM)
-
Earnings per Share (CAD) (TTM)
-
Market Cap (m USD)
84.325
Shares Outstanding (m)
38.859
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Transition Therapeutics Inc. is a biopharmaceutical company focused on developing novel therapeutics in order to address global medical needs in large disease indications, including Alzheimer's disease and diabetes.
ADDRESS
101 College Street
Suite 220
Toronto, ON M5G 1L7
Canada
PHONE
1-416-260-7770
  • Tony F Cruz
    Chairman/CEO
  • Carl Damiani
    President
  • Nicole Rusaw George
    Chief Financial Officer
  • Aleksandra Pastrak
    VP:Clinical Dev/Medical Ofcr
  • Louis Alexopoulos
    Secretary
Show More